Nexalin TechnologyInc
NXL
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.34
FAIR PRICE
$0.20
MARGIN
$0.14
P/E Ratio
N/A
Div. Yield
N/A
ROE
-207.5%
Average
Market Cap
$7M
Small-cap
COMING SOON
Get notified when NXL's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Mark White
COUNTRY
US
HEADQUARTERS
Houston
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate NXL's fair price
Nexalin TechnologyInc's fair price of $0.20 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.34, NXL trades 41.7% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting NXL's risk profile.
RELATIVE · 30%
Comparing NXL's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for NXL, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate NXL's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for NXL.
Explore on BuliosFAQ
What is the fair price of NXL?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Nexalin TechnologyInc is $0.20. At the current market price of $0.34, NXL trades 41.7% above its calculated fair value.
Is NXL overvalued or undervalued?+
Nexalin TechnologyInc is currently overvalued based on our valuation model. The stock trades at $0.34, which is 41.7% above the fair price of $0.20.
How often is NXL's fair price updated?+
We update fair price calculations for NXL daily after market close. The current fair price of $0.20 incorporates the latest market data and sector multiples.
What factors affect NXL's fair price calculation?+
NXL's fair price of $0.20 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -207.5%.
Is NXL a good buy right now?+
At $0.34, NXL trades 41.7% above our fair value estimate of $0.20. The stock is currently overvalued. ROE stands at -207.5% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does NXL pay dividends?+
NXL does not currently pay a dividend.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.